Artivion (AORT) Long-Term Debt Issuances (2010 - 2024)
Artivion posted quarterly Long-Term Debt Issuances of -$6.0 million for Q4 2024, down 103.16% on a QoQ basis from $190.0 million in Q1 2024.
Artivion (AORT) has 3 years of Long-Term Debt Issuances data on file, last reported at -$6.0 million in Q4 2024.
- For the quarter ending Q4 2024, Long-Term Debt Issuances changed N/A year-over-year to -$6.0 million; the trailing twelve-month figure through Sep 2025 stood at -$6.0 million (down 103.16% YoY), and the FY2024 full-year result was $184.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2024 stood at -$6.0 million, down from $190.0 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $190.0 million in Q1 2024 and bottomed at -$6.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -6.00 Mn |
| Dec 31, 2024 | -6.00 Mn |
| Mar 31, 2024 | 190.00 Mn |
| Mar 31, 2024 | 190.00 Mn |
| Mar 31, 2016 | 75.00 Mn |
| Mar 31, 2016 | 75.00 Mn |
| Dec 31, 2010 | -296,000.00 |
| Dec 31, 2010 | -296,000.00 |